Brain drug target discovery in MS
344280
US researchers find two potential targets for treating multiple sclerosis after studying proteins in the brain.
249246
Genentech and Biogen Idec's drug shows positive results against multiple sclerosis.
712506
GlaxoSmithKline Plc announced further  clinical trial results on Sunday underlining the ability of a  drug combination including its product Tykerb to fight breast  cancer that has spread to the brain.
658334
US scientists have mapped a key network of gene &quot;switches&quot; in the brain which could aid neurological research. These gene regulators govern whether parts of the brain develop properly.
190891
A way to combat Alzheimer&#39;s disease that uses a &quot;small&quot; molecule to block the accumulation of brain-clogging proteins is unveiled today.
539420
The AIDS virus has to hijack human proteins to do its damage, but scientists until now have known only a few dozen of its targets. On Thursday, Harvard researchers unveiled a surprisingly longer list, an important first step in the hunt for new drugs.
328996
Ablynx, a pioneer in the discovery and development of Nanobodies(TM), a new class of therapeutic antibodies, today announced that it has entered into an oncology drug discovery collaboration with Genencor ...
683001
Patients taking an experimental multiple sclerosis drug developed by Biogen Idec Inc.  and Elan Corp.  experienced far fewer relapses in a clinical trial, data that analysts say could give the drug a dominant market position.
321841
The Food and Drug Administration yesterday approved a drug for multiple sclerosis that has shown early evidence of being more effective than existing drugs.
521740
A study of cannabis-based drugs shows long-term benefit in easing multiple sclerosis symptoms, scientists say.
378759
Scientists discover a new protein they believe could help develop much more effective medicines.
75340
A gene that helps to stave off the effects of multiple sclerosis has been discovered by scientists.
288134
(Ivanhoe Newswire) -- A drug commonly used to treat the memory problems in Alzheimerâs disease may also benefit people with similar problems resulting from multiple sclerosis, find researchers from Stony Brook University Hospital in New York.
652641
WEDNESDAY, June 6 (HealthDay News) -- Anti-cancer drugs called histone deacetylase (HDAC) inhibitors improved long-term memory and strengthened neural connections in the brains of mice, says a University of California, Irvine, study.
260486
A team of Finnish researchers has developed a drug that could be a major advancement in treating degenerative diseases, including Alzheimer's. The team, working with Tampa's Johnnie B. Byrd Sr.
135926
Drugs in development could treat the cognitive deficits caused by Alzheimer's.
722720
Danish biotech firm NeuroSearch has  found enough patients to start Phase II trials with its NS2330  compound for the treatment of Alzheimer's and Parkinson's  diseases, it said on Tuesday.